Further, studies suggest a direct connection between metabolic defects, amyloid deposition, and dementia, as insulin levels can impact the production and deposition of amyloid-ß in the brain (Wei et al., 2021) and brain insulin resistance can predict development of AD in DS (Tramutola et al., 2020). The gene discussed is INS; the disease is Alzheimer disease.